BA.3.2 COVID Strain Emerges Amid Vaccination Concerns

A new COVID-19 subvariant nicknamed “Cicada” is gaining traction in California, prompting public health officials to monitor its spread amid concerns over waning immunity and seasonal transmission patterns.

The variant, scientifically designated BA.3.2, has been detected in increasing numbers across Southern California, particularly in Los Angeles County, according to genomic surveillance data from the California Department of Public Health and the U.S. Centers for Disease Control and Prevention (CDC). While not yet classified as a variant of concern by the World Health Organization, BA.3.2 carries mutations in the spike protein that may enhance transmissibility and partially evade immunity from prior infection or vaccination.

Health experts note that the emergence of BA.3.2 coincides with a broader trend of declining COVID-19 vaccine uptake, especially among high-risk populations such as seniors and immunocompromised individuals. Recent data shows that only about 40% of Californians aged 65 and older have received the updated 2024–2025 COVID vaccine, far below public health targets. This gap in protection raises concerns about potential increases in hospitalizations during the upcoming winter months, when respiratory viruses typically circulate more widely.

Although BA.3.2 does not appear to cause more severe illness than previous Omicron lineages, its ability to spread more easily could lead to higher case numbers, increasing the risk of exposure for vulnerable groups. Public health officials emphasize that vaccination remains the most effective tool to prevent serious outcomes, urging eligible residents to get the latest booster shot, which has been updated to target recent Omicron subvariants.

In response to the rising detection of BA.3.2, local health departments in Los Angeles and San Diego have intensified wastewater monitoring and expanded access to free testing sites. The CDC continues to track the variant through its National SARS-CoV-2 Strain Surveillance (NS3) system, which analyzes genetic sequences from patient samples nationwide.

Experts caution that while the current situation does not warrant alarm, it underscores the importance of sustained vigilance. “We’re not seeing a crisis, but we are seeing a signal,” said Dr. Elena Rodriguez, an epidemiologist at the University of California, San Francisco. “The virus continues to evolve, and our defenses need to keep pace — especially for those most at risk.”

As of mid-April 2026, California reports a modest rise in outpatient visits for COVID-like symptoms, though emergency department admissions remain stable. Health authorities recommend that individuals, particularly those over 65 or with underlying conditions, consider wearing masks in crowded indoor settings and stay up to date with vaccinations to reduce personal risk during periods of increased viral activity.